Skip to content

HydroMARK Breast Biopsy Site Marker CA000407009Recalls & reported problems

Devicor Medical Products, Inc. · HydroMARK Breast Biopsy Site Marker-CE · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00841911102151), received between Mar 25, 2021 and Mar 25, 2021 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Hypersensitivity/Allergic reaction1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 25, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT EXPERIENCED A POTENTIAL ALLERGIC REACTION AFTER THE BIOPSY BREAST MARKER (HYDROMARK) WAS INSERTED IN THE MORNING AND SUBSEQUENTLY DEVELOPED DIFFUSE UTICARIAL TYPE RASH OVER THE BODY AND SHORTNESS OF BREATH IN THE EVENING. PATIENT ATTENDED ED DEPARTMENT FOR INVESTIGATION - SYMPTOMS RESOLVED, TREATMENT FOR REACTION (UTICARIA) WAS NOT SPECIFIED AND TREATMENT FOR REACTION (SHORTNESS OF BREATH) WAS NOT SPECIFIED. THIS INCIDENT HAS BEEN RECORDED IN COMPLAINT #(B)(4).

    Patient problems: Hypersensitivity/Allergic reaction

    MAUDE report 11572811 ↗

Other Marker, Radiographic, Implantable devices

All Marker, Radiographic, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page